Clinical Trial Update: COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study [Phase 2]

View source ↗

Summary

Phase 2 COSMO trial evaluating whether continuing the same systemic therapy after local ablative therapy for oligoprogression in metastatic breast cancer is ben…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Breast Cancer Invasive, Metastatic Cancer | Phase 2 | Status: RECRUITING